tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Potential of Tenax Therapeutics’ TNX-103 Drives Buy Rating Amid Positive Phase 2 Results and Anticipated Phase 3 Trial
PremiumRatingsPromising Potential of Tenax Therapeutics’ TNX-103 Drives Buy Rating Amid Positive Phase 2 Results and Anticipated Phase 3 Trial
2M ago
Tenax Therapeutics initiated with an Overweight at Piper Sandler
Premium
The Fly
Tenax Therapeutics initiated with an Overweight at Piper Sandler
2M ago
Tenax Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Tenax Therapeutics Reports Q2 2025 Financial Results
3M ago
Tenax Therapeutics Reports Increased Losses Amid Strategic Investments
PremiumCompany AnnouncementsTenax Therapeutics Reports Increased Losses Amid Strategic Investments
5M ago
Positive Buy Rating for Tenax Therapeutics Driven by Promising Clinical Trials and Strong Financial Position
Premium
Ratings
Positive Buy Rating for Tenax Therapeutics Driven by Promising Clinical Trials and Strong Financial Position
5M ago
Tenax Therapeutics price target lowered to $15 from $16 at Guggenheim
Premium
The Fly
Tenax Therapeutics price target lowered to $15 from $16 at Guggenheim
6M ago
Tenax Therapeutics reports Q4 EPS (18c), consensus (43c)
PremiumThe FlyTenax Therapeutics reports Q4 EPS (18c), consensus (43c)
7M ago
Is TENX a Buy, Before Earnings?
Premium
Pre-Earnings
Is TENX a Buy, Before Earnings?
7M ago
Promising Developments and Financial Backing Drive Buy Rating for Tenax Therapeutics
Premium
Ratings
Promising Developments and Financial Backing Drive Buy Rating for Tenax Therapeutics
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100